Condition (MeSH)
Colitis, Lymphocytic
ClinicalTrials.gov lists 6 trials for Colitis, Lymphocytic or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
6 of the 6 trials are tagged with Colitis, Lymphocytic itself; the rest are tagged with a narrower condition beneath it.
When did Colitis, Lymphocytic trials start? (6)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2/3
- Phase 3
- Not applicable
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2022 | 1 |
| 2014 | 1 |
| 2010 | 1 |
| 2009 | 1 |
| 2003 | 1 |
| 2002 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 6 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Colitis, Lymphocytic trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2/3 | 1 |
| Phase 3 | 2 |
| Not applicable | 1 |
| Observational | 2 |
How many Colitis, Lymphocytic trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 3 |
| Terminated | 2 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Colitis, Lymphocytic trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Dr. Falk Pharma GmbH | 1 |
| Viome | 1 |
Which publications cover Colitis, Lymphocytic? (8)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| An altered composition of the microbiome in microscopic colitis is driven towards the composition in healthy controls by treatment with budesonide. | Scandinavian journal of gastroenterology | 2019 | Yes |
| Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis. | Gastroenterology | 2018 | Yes |
| Clinical characteristics and patterns and predictors of response to therapy in collagenous and lymphocytic colitis. | Scandinavian journal of gastroenterology | 2015 | Yes |
| Chronic non-bloody diarrhoea: a prospective study in Malmö, Sweden, with focus on microscopic colitis. | BMC research notes | 2014 | Yes |
| Epidemiological risk factors in microscopic colitis: a prospective case-control study. | Inflammatory bowel diseases | 2013 | Yes |
Showing 5 of 8 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.